SCHEMBL22876178

SCHEMBL22876178

c1ccc(-c2ccc(-c3ccccc3-n3c4ccccc4c4cc(-c5ccc6c(c5)c5ccccc5n6-c5ccccc5)ccc43)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.53
KDM4E B2RXH2 1/20 0.53
ATM Q13315 1/20 0.53
TSPO P30536 1/20 0.40
ALDH1A1 P00352 2/20 0.40
KMT2A Q03164 2/20 0.38
IL1R1 P14778 1/20 0.38
HDAC4 P56524 1/20 0.38
MEN1 O00255 1/20 0.38
MAPT P10636 1/20 0.38
HTT P42858 1/20 0.38
PTGER4 P35408 1/20 0.36
DNM1 Q05193 1/20 0.35
MGLL Q99685 1/20 0.35
HSD17B10 Q99714 1/20 0.35
KDR P35968 1/20 0.35
AVPR1A P37288 1/20 0.33
HTR1A P08908 1/20 0.33
HTR2A P28223 1/20 0.33
HTR7 P34969 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25671844 1.00 L3MBTL1 (0.53) L3MBTL1KDM4EATMTSPOALDH1A1
SCHEMBL22876398 1.00 L3MBTL1 (0.53) L3MBTL1KDM4EATMTSPOALDH1A1
SCHEMBL25941169 1.00 L3MBTL1 (0.53) L3MBTL1KDM4EATMTSPOALDH1A1
SCHEMBL20707542 1.00 L3MBTL1 (0.53) L3MBTL1KDM4EATMTSPOALDH1A1
SCHEMBL25671855 1.00 L3MBTL1 (0.53) L3MBTL1KDM4EATMTSPOALDH1A1
SCHEMBL26480940 0.99 L3MBTL1 (0.51) L3MBTL1KDM4EATMTSPOALDH1A1
SCHEMBL25919274 0.99 L3MBTL1 (0.51) L3MBTL1KDM4EATMTSPOALDH1A1
SCHEMBL26481053 0.99 L3MBTL1 (0.51) L3MBTL1KDM4EATMTSPOALDH1A1
SCHEMBL18779640 0.98 L3MBTL1 (0.55) L3MBTL1KDM4EATMTSPOALDH1A1
SCHEMBL31592721 0.98 L3MBTL1 (0.55) L3MBTL1KDM4EATMTSPOALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024150673-A1 MIXED COMPOSITION AND ORGANIC ELECTROLUMINESCENT DEVICE 日鉄ケミカル&マテリアル株式会社 2024-07-18 WO disclosed
US-20240228496-A1 DEUTERIDE AND ORGANIC ELECTROLUMINESCENT ELEMENT NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2024-07-11 US disclosed
US-20240228496-A1 DEUTERIDE AND ORGANIC ELECTROLUMINESCENT ELEMENT NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2024-07-11 US disclosed
US-20240237523-A1 DEUTERIDE AND ORGANIC ELECTROLUMINESCENT ELEMENT NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2024-07-11 US disclosed
US-20240237523-A1 DEUTERIDE AND ORGANIC ELECTROLUMINESCENT ELEMENT NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2024-07-11 US disclosed
US-11685859-B2 Organic light emitting device LG CHEM, LTD. (KR) 2023-06-27 US disclosed
US-11685859-B2 Organic light emitting device LG CHEM, LTD. (KR) 2023-06-27 US disclosed
US-20230200233-A1 COMPOSITION, ELECTRONIC COMPOMENT AND ELECTRONIC DEVICE CONTAINING THE COMPOSITION SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-06-22 US disclosed
US-20230200233-A1 COMPOSITION, ELECTRONIC COMPOMENT AND ELECTRONIC DEVICE CONTAINING THE COMPOSITION SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-06-22 US disclosed
US-20210009894-A1 ORGANIC LIGHT EMITTING DEVICE LG CHEM, LTD. (KR) 2021-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240228496-A1 DEUTERIDE AND ORGANIC ELECTROLUMINESCENT ELEMENT LEF1, WEE2, CTNNA1 L3MBTL1 488/4885KDM4E 1781/4885ATM 4552/4885
US-20240237523-A1 DEUTERIDE AND ORGANIC ELECTROLUMINESCENT ELEMENT LEF1, OR51E2, WEE2 L3MBTL1 633/4885KDM4E 1745/4885ATM 4378/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.